Quote: “Selenium most probably has a protective role against the development of prostate cancer and its progression to advanced stages. Therefore, selenium supplementation can be proposed for prevention of prostate cancer.”
These words are taken from the conclusion of a 2018 systematic review and meta-analysis of studies of the association between selenium and prostate cancer [Sayehmiri].
The meta-analysis is based on the data from 38 journal medical articles that included 36,419 prostate cancer cases and 105,293 healthy controls. There were 22 case-control studies, 6 cohort studies, and 10 randomized controlled trials included in the meta-analysis [Sayehmiri].
Selenium levels associated with risk of prostate cancer
The pooled relative risk from the 38 studies of the association of selenium concentration and prostate cancer risk showed a statistically significant 14% risk reduction with higher levels of blood selenium or toe nail selenium.
Blood selenium concentrations are significantly lower in patients with Alzheimer’s disease compared to healthy controls. This reduction in selenium concentration is directly associated with the observed reduced levels of the important antioxidant selenoprotein, glutathione peroxidase, in Alzheimer’s disease patients.
These are the conclusions of the authors of a 2017 meta-analysis of 12 case-control studies of selenium concentrations in Alzheimer’s disease patients and healthy controls. The 12 case-control studies comprised 594 Alzheimer’s disease patients and 472 healthy controls [Reddy].
Significantly decreased selenium levels were seen in the blood circulation of Alzheimer’s disease patients as compared to healthy controls.
Decreased selenium levels were also seen in the red blood cells and cerebrospinal fluid of Alzheimer’s patients as compared to healthy controls. However, the difference in selenium concentrations did not reach the level of statistical significance.
Age matching between the Alzheimer’s disease patients and healthy controls showed decreased selenium levels regardless of the age of the patients. This is interesting because advanced age is considered a risk factor for Alzheimer’s disease.
Controlling for socio-economic, geographical, and environmental differences also showed the decreased selenium levels in Alzheimer’s disease patients compared to the healthy controls.
A direct association was seen between decreased selenium levels and glutathione peroxidase levels in Alzheimer’s disease patients.
What is glutathione peroxidase, and why is it important?
The glutathione peroxidases (abbreviated GPx) are a family of antioxidant enzymes (selenoproteins) that reduce and thus neutralize potentially harmful radicals like hydrogen peroxide and lipid hydroperoxides. In so doing, the GPx enzymes lessen the extent of oxidative stress damage.
The other day, I saw an interesting question: how can we make this boring trace element interesting?
The reference was to selenium, the element in the periodic table with the atomic number 34. As a component of the selenium-dependent selenoproteins, selenium has numerous biological functions in the body:
Antioxidant protection of the cells against harmful free radical damage
Counteraction of DNA mutation
Inhibition of chronic low-grade inflammation
Optimal production of thyroid hormones
Proper reproduction of cells
Protection of lymph channels and blood vessel walls
Reduced risk of certain types of cancer
Reduced risk of cardiovascular disease
Regeneration of the antioxidant forms of vitamin C, vitamin E, and Coenzyme Q10
And, yet, hardly anyone has heard about selenium as an important bio-nutrient. No one ever has a blood test done to see if he or she has adequate plasma selenium concentrations.
Selenium intakes vary considerably from region to region, from culture to culture, and certainly from diet to diet. It is difficult to get a handle on how much selenium we get from our food.
The amount of selenium we get from our food depends on the soil where the food was grown. Generally, Americans living on the East Coast and in the Pacific Northwest get less selenium in their food than do Americans in the middle of the country. But even that depends on the composition of the meals that the individuals eat.
Selenium is essential in small amounts; however, at excessively high levels, it can be harmful in the long run.
The human body does not synthesize selenium itself. Without adequate selenium in the diet and from supplements, there will not be enough selenium for incorporation into the amino acid selenocysteine. Selenocysteine is, then, a necessary component for the synthesis in the body of the 25 known selenoproteins.
The Functions of the Selenoproteins
At present, we know of 25 genes that code for the synthesis of selenoproteins in the body.
*** There are eight known glutathione peroxidases, many of which have important antioxidant protection functions in various compartments of the body.
Low plasma/serum selenium concentrations are associated with increased risk of death from heart disease and increased risk of death from all causes. Professor Urban Alehagen and a team of researchers at Linköping University in Sweden have investigated the relationship between low selenium levels and the risk of heart disease.
Selenium supplements suggested for adults with very low Se levels
The Swedish study shows that adults with a serum selenium concentration below 57 micrograms per liter are at significantly higher risk of death from all causes (43% increased risk) and death from heart disease (56% increased risk) [Alehagen 2016].
57 micrograms of selenium per liter of serum. Wow! That’s low.
These significant associations remained solid even after the researchers had adjusted for the effects of possibly modifying factors:
Combining high-selenium yeast and Coenzyme Q10 supplements gives elderly people in low selenium regions good protection against heart disease. That seems to be the take-home lesson from a 12-year follow-up analysis of the Swedish KiSel-10 study [Alehagen 2018].
Protective effects of selenium and CoQ10 persist 12 years
Originally, Professor Urban Alehagen and researchers at the University in Linköping enrolled 443 elderly Swedish citizens who were living in a community in which selenium intakes in the food were known to be low. They randomly assigned the study participants to take a combination of 200 micrograms of selenium in a high-selenium yeast tablet and 200 milligrams of Coenzyme Q10 daily or to take matching placebos. The supplementation study lasted for four years [Alehagen 2013].
The results of clinical studies give us an estimate of what an individual’s optimal serum or plasma selenium status is.
Plasma selenium status below 100 micrograms per liter – also expressed as 100 nanograms per milliliter – is generally regarded as sub-optimal plasma selenium status [Hurst 2010].
Plasma selenium status of at least 110 – 118 micrograms per liter is considered necessary for the optimal expression of selenoprotein P [Hurst 2010].
Letsiou et al  set the lower limit for optimal selenoprotein P activity at 120 micrograms per liter or higher.
Plasma selenium status of 120 up to 170 micrograms per liter is considered necessary for reducing the risk of prostate cancer [Hurst 2012].
Studies show that there are sex and age differences in the absorption and distribution of selenium taken in from the diet and from supplements [Letsiou 2014; Galan 2005].
Note: The Mayo Medical Laboratories report serum concentrations of 70 to 150 micrograms per liter as the adult reference range for residents of the United States. The mean population serum concentration is 98 micrograms per liter [Mayo], but, remember, depending on the range and standard deviation of the data, the mean can be very little useful. The important thing about the United States is that there is regional variation in selenium intakes and status. See below.
Selenium intake and selenium status
The primary sources of selenium are the diet and supplements. The human body does not synthesize selenium. It is difficult to calculate accurately how much selenium an individual gets from food. It can also be difficult to know precisely how much selenium an individual absorbs from a supplement because of the variation in the form and formulation of the selenium supplements on the market.
Typically, the serum selenium concentration levels are significantly lower in women with gestational diabetes than in healthy pregnant women. The differences are especially remarkable in non-Caucasian pregnant women and in pregnant women in the third trimester. That is the finding of a recent meta-analysis and systematic review of the relevant literature from observational studies [Kong 2016].
Selenium and gestational diabetes
Gestational diabetes is defined as any degree of glucose intolerance that occurs with the onset of pregnancy. A physiological insulin resistance beginning in the second trimester and progressing through the third trimester is fairly typical of pregnancies. Expecting mothers generally need increased insulin secretion to maintain normal blood glucose levels. Impairment of the needed compensatory increases in insulin secretion leads to a diagnosis of gestational diabetes [Kong 2016].
We want stability, safety, and bio-availability from our selenium supplement. The high-selenium yeast supplement – also known as the selenium-enriched yeast supplement – is the best formulation to achieve these goals.
High-selenium yeast supplements are produced using the selenium that has been grown with Saccharomyces cerevisiae yeast (baker’s yeast). Those of us who take a daily high-selenium yeast supplement know that the yeast used in the making of the supplement is dead. The yeast cells cannot get into our bodies and multiply because they are not alive.
Various forms of selenium supplements
There are both inorganic and organic forms of selenium in commercially available selenium supplements. There are supplements made with inorganic forms containing selenium salts like sodium selenite and sodium selenate. Their absorption is not nearly as good as the absorption of the best organic selenium-enriched yeast supplements.
In a recent article on the web-site q10facts.com, I have posted a summary of an article in which researchers discuss the various ways in which statin medications may increase patients’ risk of atherosclerosis and heart failure. Yes, the Japanese and American researchers say, the statin medications do lower cholesterol levels [Okuyama].
But, the guidelines for the use of statin medications need to be re-examined. The researchers say: There has been a remarkable increase in the incidence of heart failure in the same period that statin medications have been used [Okuyama].
Furthermore, there are known mechanisms by which statin medications could be causing an increase in the incidence of atherosclerosis and heart failure.
Selenium containing antioxidant selenoproteins play an important role in the prevention and reversal of oxidative damage in the brain. This role has generally been underestimated in studies of the toxicity of elemental mercury and methylmercury. The common understanding has been that selenium helps to prevent mercury toxicity by binding with mercury and rendering the mercury inactive.
This chemical binding and inactivation of mercury does take place. Mercury has a great affinity for selenium, estimated to be approximately one million times stronger than mercury’s affinity for sulfur. So, selenium’s binding with mercury in the tissues does keep the mercury from getting into mischief in the brain and spinal cord, peripheral nervous system, and endocrine system.